238 related articles for article (PubMed ID: 6542154)
1. [Tissue plasminogen activator].
Matsuo O
Rinsho Ketsueki; 1984 Jul; 25(7):1004-10. PubMed ID: 6542154
[No Abstract] [Full Text] [Related]
2. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
Gurewich V; Pannell R
Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
[No Abstract] [Full Text] [Related]
3. [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].
Bode C; Eberle T; Runge M; Haber E; Kübler W
Verh Dtsch Ges Inn Med; 1990; 96():1-3. PubMed ID: 2128723
[No Abstract] [Full Text] [Related]
4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
5. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
Bode C; Runge M; Eberle T; Freitag M; Kübler W; Haber E
Trans Assoc Am Physicians; 1989; 102():7-12. PubMed ID: 2517856
[No Abstract] [Full Text] [Related]
6. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
[TBL] [Abstract][Full Text] [Related]
7. Serine-proteases as plasminogen activators in terms of fibrinolysis.
Flemmig M; Melzig MF
J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic agents.
Schmitz-Huebner U; van de Loo J
Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
[No Abstract] [Full Text] [Related]
9. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
Gurewich V
Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
[No Abstract] [Full Text] [Related]
10. [The RH-PA cell line--a source for obtaining the urokinase-type plasminogen activator].
Kapina MA; Zelenin MG; Glukhova LA; Egorov BB
Antibiot Khimioter; 1989 Dec; 34(12):893-8. PubMed ID: 2517003
[TBL] [Abstract][Full Text] [Related]
11. [Plasminogen activator from a kidney cell culture].
Andreenko GV; Egorov BB; Liaginskiĭ AV; Serebriakova TN; Podorol'skaia LV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (10):55-8. PubMed ID: 6686063
[TBL] [Abstract][Full Text] [Related]
12. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
Lijnen HR; Stump DC; Collen DC
Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
[No Abstract] [Full Text] [Related]
13. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
Páramo JA; Fernández FJ; Cuesta B; Paloma MJ; Rocha E
Sangre (Barc); 1989 Aug; 34(4):297-9. PubMed ID: 2505395
[No Abstract] [Full Text] [Related]
14. Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis.
Electricwala A; Emeis JJ; Atkinson T
J Pharmacol Exp Ther; 1986 Jul; 238(1):254-8. PubMed ID: 2425075
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
Juhan-Vague I; Stassen JM; Alessi MC; Elias A; Aillaud MF; Serradimigni A; Collen D
Semin Thromb Hemost; 1989 Oct; 15(4):390-4. PubMed ID: 2554499
[No Abstract] [Full Text] [Related]
16. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Thorsen S
Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
[No Abstract] [Full Text] [Related]
17. [Combined thrombolysis by pharmacokinetically different plasminogen activators].
Maksimenko AV
Bioorg Khim; 1998 May; 24(5):376-80. PubMed ID: 9661792
[TBL] [Abstract][Full Text] [Related]
18. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
Páramo JA; Collen D
Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
[No Abstract] [Full Text] [Related]
19. [Thrombolytics and their use].
Alessi MC; Juhan-Vague I
Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
[TBL] [Abstract][Full Text] [Related]
20. [Synthetic compounds with fibrinolytic and thrombolytic activity. I. Pharmacologic observations].
Desnoyers P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):351-6. PubMed ID: 63421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
